O'Leary M A, Isbister G K
Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, Australia.
Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, Australia; School of Medicine and Public Health, University of Newcastle, Australia.
Toxicon. 2014 Jan;77:125-32. doi: 10.1016/j.toxicon.2013.11.001. Epub 2013 Nov 16.
The measurement of free venom with enzyme immunoassay in serum of patients with snake envenoming is used to confirm snake identification and to determine if sufficient antivenom has been given. Recent studies with Russell's viper (RV; Daboia russelii) envenoming have detected free venom post-antivenom despite recovery of coagulopathy. This raises the question as to whether this assay also measures venom-antivenom (VAV) complexes. In this study we developed an assay to measure VAV complexes and investigate the binding of venom and antivenom in vitro. The assay consisted of rabbit anti-snake venom IgG attached to a microplate which binds the venom component of VAV and anti-horse IgG antibodies conjugated to horseradish peroxidase to detect the antivenom portion of VAV. A known amount of venom or toxin was incubated with increasing antivenom concentrations and VAV was detected as absorbance at 450 nm and plotted against AV concentration. Pseudonaja textilis (brown snake), Notechis scutatus (tiger snake), Oxyuranus scutellatus (taipan), Tropidechis carinatus (rough-scaled snake), Pseudechis porphyriacus (red-bellied black snake) and D. russelii mixtures with appropriate antivenoms were assayed. Measured VAV initially increased with increasing antivenom concentration until it reached a maximum after which the VAV concentration decreased with further increasing antivenom concentrations. The VAV curves for two Australian snake venom-antivenom mixtures, Hoplocephalus stephensii and Ancanthophis antarcticus, had broad VAV peaks with two maxima. Two fractions isolated from N. scutatus venom and Russell's viper factor X activator toxin produced similar VAV curves to their whole venoms. The antivenom concentration for which the maximum VAV occurred was linearly related to the venom concentration, and this slope or ratio was consistent with that used to define the neutralisation units for Australian antivenoms. The maximal VAV point appears to represent the antivenom concentration where every venom molecule (toxin) is attached to at least one antivenom molecule (antibody) on average and may be a useful measure of antivenom efficacy. In vivo this would mean that for a defined antivenom concentration, venom components will be eliminated and are trapped in the central compartment.
采用酶免疫分析法检测蛇伤患者血清中的游离毒素,用于确定蛇的种类以及判断是否已给予足够的抗蛇毒血清。近期针对罗素蝰蛇(RV;Daboia russelii)咬伤的研究发现,尽管凝血功能障碍已恢复,但在给予抗蛇毒血清后仍能检测到游离毒素。这就引发了一个问题,即该检测方法是否也能检测毒液 - 抗蛇毒血清(VAV)复合物。在本研究中,我们开发了一种检测VAV复合物的方法,并在体外研究了毒液与抗蛇毒血清的结合情况。该检测方法包括将兔抗蛇毒IgG附着于微孔板上,其可结合VAV的毒液成分,以及将与辣根过氧化物酶偶联的抗马IgG抗体用于检测VAV的抗蛇毒血清部分。将已知量的毒液或毒素与不断增加的抗蛇毒血清浓度进行孵育,通过检测450 nm处的吸光度来检测VAV,并将其与抗蛇毒血清浓度作图。对伪眼镜蛇(棕蛇)、盾鼻蛇(虎蛇)、太攀蛇、糙鳞蛇、红腹黑蛇以及罗素蝰蛇与相应抗蛇毒血清的混合物进行了检测。测得的VAV最初随着抗蛇毒血清浓度的增加而升高,直至达到最大值,此后随着抗蛇毒血清浓度的进一步增加,VAV浓度降低。两种澳大利亚蛇毒 - 抗蛇毒血清混合物(斯蒂芬小头蛇和南极棘蛇)的VAV曲线具有较宽的VAV峰,有两个最大值。从盾鼻蛇毒液中分离出的两个组分以及罗素蝰蛇因子X激活毒素产生的VAV曲线与其全毒液相似。出现最大VAV时的抗蛇毒血清浓度与毒液浓度呈线性相关,且该斜率或比值与用于定义澳大利亚抗蛇毒血清中和单位的一致。最大VAV点似乎代表了这样一种抗蛇毒血清浓度,即平均每个毒液分子(毒素)至少与一个抗蛇毒血清分子(抗体)结合,这可能是衡量抗蛇毒血清疗效的一个有用指标。在体内,这意味着对于确定的抗蛇毒血清浓度,毒液成分将被清除并被困在中央隔室中。